Moreover, the aberrant expressions of some lncRNAs mentioned in this review have also been shown to underlie the onset and pathogenesis of other cancers, such as MALAT1 and SNHG14, which seem to be possible diagnostic and prognostic therapeutic biomarkers in colorectal and hepatocellular cancer [129,130]. The gene discussed is MALAT1; the disease is hepatocellular carcinoma.